97542504 - CSL SEQIRUS

Information

• Trademark
• 97542504

• Source

• Serial Number

  97542504

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  August 10, 2022
  2 years ago

• Transaction Date

  September 20, 2024
  2 months ago

• Status Date

  September 19, 2024
  2 months ago

• Published for Opposition Date

  January 30, 2024
  10 months ago

• Location Date

  March 26, 2024
  8 months ago

• Status Code

  730

• Current Location

  INTENT TO USE SECTION

  Employee Name

  CAYSIDO, REBECCA

• Attorney Name

  Nancy Sabarra

  Law Office Assigned Location Code

  N50

• Owners

  • Seqirus UK Limited

Case File Statements

• GS0411: Education services including medical education services, namely, conducting classes, seminars, conferences, and workshops in the fields of pharmaceuticals, vaccines, biotechnology, biotherapy, immunology, rare diseases and blood conditions; health education, namely, providing classes in the field of health, vaccines, and immunology; consultancy services relating to education; provision of education services, namely, arranging and conducting of online conferences and symposia in the field of medical science via an online forum; provision of medical training and education courses in the field of health and medicine; publication of electronic educational materials; dissemination of printed and electronic educational material of others in the field of health and medicine; weblog services, namely, providing online non-downloadable blogs in the field of health and medicine; electronic publication of information on a wide range of topics, including online and over a global computer network, namely, electronic publishing of electronic publications featuring information on a wide range of topics
• GS0051: Pharmaceutical preparations and substances for the treatment and prevention of influenza, respiratory disease and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, stroke, and heart failure; pharmaceutical preparations and substances, namely, anti-virals and antibiotics; vaccines; blood products, namely, blood for medical purposes, blood plasma and cord blood for medical purposes; serums, namely, anti-venoms; medicated serums for the treatment of blood disorders and bleeding disorders; antibodies for use in the treatment of infectious diseases, cancer and autoimmune diseases; monoclonal and polyclonal antibodies for medical purposes; therapeutic monoclonal and polyclonal antibodies and antibodies for use in the treatment of infectious diseases; influenza vaccines; adjuvants for medical purposes and antigens being protein arrays for medical purposes; pharmaceutical preparations and substances for the treatment and prevention of blood or bleeding disorders; blood products, namely, blood plasma, reagent blood cells for medical use; products derived from blood and products derived from recombinant DNA technology, namely, blood substitutes being immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for therapeutic human use; test kits, namely, invitro diagnostic reagent test kits comprised of medical diagnostic reagents for use in detecting cell mediated immune response; pharmaceutical preparations and substances, namely, RhD reagents for medical use for the detection of specific antigens and in blood typing; pharmaceutical preparations, namely, reagent red blood cells for medical purposes used to detect antibodies or IgG subtypes; pharmaceutical preparations, namely, monoclonal and polyclonal antibodies for pharmaceutical use; pharmaceutical preparations, namely, reagents for medical and clinical use for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes; diagnostic agents for medical purposes
• GS0011: Chemical and biological reagents for scientific purposes, research purposes, and non-medical purposes; cell culture reagents and media for scientific and research use; laboratory and scientific test kits for laboratory or research use, namely, reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields; chemical preparations for scientific and industrial purposes; diagnostic and testing agents, namely, diagnostic reagents and diagnostic testing preparations for scientific and research use; chemical and biological reagents for non-medical purposes; chemical and biological reagents for industrial use for antibody screening, blood grouping, and for the typing and detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes all for non-medical purposes; chemical test kits for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for industrial use for anti-body screening, blood grouping, and the typing and detection of specific blood cells
• GS0441: Medical services; medical information services; health care services; health care information services; patient support services, namely, providing an internet-based database of patient medical information where patients can inquire about medical issues and procedures related to vaccination and immunology; providing medical information concerning blood products; providing medical information concerning vaccines, anti-venoms and immunohaematology products being diagnostic reagents; patient support services, namely, providing patient medical information where patients can enquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community via an Internet-based database
• GS0421: Scientific and technological services, namely, scientific research and product development in the field of vaccines; scientific research, analysis, and testing in the field of medicine, pharmaceuticals, vaccines, and biotechnology; research and development services, namely, scientific, medical, pharmaceutical and blood products research and development services; industrial analysis of biotechnology and immunology processes for product development in the field of pharmaceuticals and vaccines; providing medical research and scientific research information about the results of clinical trials for pharmaceuticals and vaccines; providing medical research and scientific research information in the field of clinical trials; provision of testing facilities for pharmaceutical research; laboratory analysis and research in the fields of pharmaceuticals, vaccines, bacteriology, and chemistry; management of scientific research projects; providing technical research in the field of pharmaceutical studies through preparation of technical studies, technical reports, scientific reports; providing technical research in the field of pharmaceutical studies through preparation of scientific and medical research projects, preparation of statistics and reports relating to scientific and medical research; provision of scientific research services and facilities, provision of scientific research results, information and outcomes in the field of health and medicine; provision of pharmaceutical research information relating to the aforementioned services; pharmaceutical research advisory and consultancy services relating to the aforementioned services; dissemination of pharmaceutical research and medical research information relating to the aforementioned services over a global computer network; medical laboratory services through scientific testing and screening services, namely, medical laboratory testing of human blood plasma for safety and quality; medical laboratory services regarding human blood plasma

Case File Event Statements

• 8/13/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 8/30/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 5/30/2023 - a year ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 6/5/2023 - a year ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/5/2023 - a year ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 6/5/2023 - a year ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 8/15/2023 - a year ago

  7 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 8/15/2023 - a year ago

  8 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG

• 12/5/2023 - a year ago

  9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/5/2023 - a year ago

  10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/6/2023 - 12 months ago

  11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/28/2023 - 11 months ago

  12 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 12/28/2023 - 11 months ago

  13 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 12/28/2023 - 11 months ago

  14 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 12/28/2023 - 11 months ago

  15 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 12/28/2023 - 11 months ago

  16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/10/2024 - 10 months ago

  17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/30/2024 - 10 months ago

  18 - PUBLISHED FOR OPPOSITION Type: PUBO

• 1/30/2024 - 10 months ago

  19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 3/26/2024 - 8 months ago

  20 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 9/19/2024 - 2 months ago

  21 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 9/19/2024 - 2 months ago

  22 - SOU EXTENSION 1 FILED Type: EXT1

• 9/19/2024 - 2 months ago

  23 - SOU EXTENSION 1 GRANTED Type: EX1G

• 9/19/2024 - 2 months ago

  24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA